scientists yesterday reported significant promise in the century-long struggle to develop a vaccine against malaria reuter reports from washington malaria kills up to 1 m children each year in africa and there are up to 500 m cases of the disease each year globally moreover the disease is showing resistance to drugs traditionally used to treat it scientists working for a special tropical disease programme jointly sponsored by the un development programme the world bank and the world health organisation said a vaccine known as spf66 has shown promising results in the first phases of human trials in a region of africa with rampant malaria a final phase of human tests of the vaccine under way in tanzania gambia colombia and thailand will determine whether spf66 actually reduces the number of malaria attacks if those tests are successful a vaccine could be available for widespread use by 1998